Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-28 @ 7:38 PM
Study NCT ID:
NCT04781634
Status:
RECRUITING
Last Update Posted:
2025-02-25
First Post:
2021-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL
Sponsor:
Chongqing Precision Biotech Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-26
First Submit QC Date:
None
Study First Post Date:
2021-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-23
Last Update Post Date:
2025-02-25
Last Update Post Date Type:
ACTUAL